CD14: A soluble pattern recognition receptor in milk

Advances in Experimental Medicine and Biology

Volumn 606, Issue , 2008, Pages 195-216

  Vidal, Karine ^a   Donnet Hughes, Anne ^b  

^a NESTLÉ RESEARCH CENTER   (Switzerland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; GLYCOLIPID; GLYCOPROTEIN; IMMUNOGLOBULIN; PATTERN RECOGNITION RECEPTOR; POLYPEPTIDE ANTIBIOTIC AGENT; TOLL LIKE RECEPTOR;

AMINO ACID SEQUENCE; ANTIGEN EXPRESSION; BREAST MILK; GENE MAPPING; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; MILK; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION;

EID: 84934440654     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-74087-4_7     Document Type: Review

References (179)

1. Abreu, M. T., Vora, P., Faure, E., Thomas, L. S., Arnold, E. T., & Arditi, M. (2001). Decreased expression of Toll-like receptor-4 and MD-2 correlates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide. Journal of Immunology, 167, 1609-1616.
2. Aderem, A. & Ulevitch, R. J. (2000). Toll-like receptors in the induction of the innate immune response. Nature, 406, 782-787.
3. Arditi, M., Zhou, J., Dorio, R., Rong, G. W., Goyert, S. M., & Kim, K. S. (1993). Endotoxinmediated endothelial cell injury and activation: Role of soluble CD14. Infectious Immunology, 61, 3149-3156.
4. Arias, M. A., Rey Nores, J. E., Vita, N., Stelter, F., Borysiewicz, L. K., Ferrara, P., et al. (2000). Cutting edge: Human B cell function is regulated by interaction with soluble CD14: Opposite effects on IgG1 and IgE production. Journal of Immunology, 164, 3480-3486.
5. * in the 5' flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E. American Journal of Respiriratory Cell and Molecular Biology, 20, 976-983.
6. Bannerman, D. D., Paape, M. J., Hare, W. R., & Sohn, E. J. (2003). Increased levels of LPS-binding protein in bovine blood and milk following bacterial lipopolysaccharide challenge. Journa of Dairy Science, 86, 3128-3137.
7. Bas, S., Gauthier, B. R., Spenato, U., Stingelin, S., & Gabay, C. (2004). CD14 is an acutephase protein. Journal of Immunology, 172, 4470-4479.
8. Baveye, S., Elass, E., Fernig, D. G., Blanquart, C., Mazurier, J., & Legrand, D. (2000). Human lactoferrin interacts with soluble CD14 and inhibits expression of endothelial adhesion molecules, E-selectin and ICAM-1, induced by the CD14-lipopolysaccharide complex. Infectious Immunology, 68, 6519-6525.
9. Bazil, V., & Strominger, J. L. (1991). Shedding as a mechanism of down-modulation of CD14 on stimulated human monocytes. Journal of Immunology, 147, 1567-1574.
10. Bazil, V., Horejsi, V., Baudys, M., Kristofova, H., Strominger, J. L., Kostka, W., et al. (1986). Biochemical characterization of a soluble form of the 53-kDa monocyte surface antigen. European Journal of Immunology, 16, 1583-1589.
11. Bazil, V., Baudys, M., Hilgert, I., Stefanova, I., Low, M. G., Zbrozek, J., et al. (1989). Structural relationship between the soluble and membrane-bound forms of human monocyte surface glycoprotein CD14. Molecular Immunology, 26, 657-662.
12. Berg, R. D. (1996). The indigenous gastrointestinal microflora. Trends in Microbiology, 4, 430-435.
13. Blais, D. R., Vascotto, S. G., Griffith, M., & Altosaar, I. (2005). LBP and CD14 secreted in tears by the lacrimal glands modulate the LPS response of corneal epithelial cells. Investigative Ophthalmology and Visual Science, 46, 4235-4244.
14. Blais, D. R., Harrold, J., & Altosaar, I. (2006). Killing the messenger in the nick of time: Persistence of breast milk sCD14 in the neonatal gastrointestinal tract. Pediatric Research, 59, 371-376.
15. Bloomfield, S. F., Stanwell-Smith, R., Crevel, R. W., & Pickup, J. (2006). Too clean, or not too clean: The hygiene hypothesis and home hygiene. Clinical and Experimental Allergy, 36, 402-425.
16. Bufler, P., Stiegler, G., Schuchmann, M., Hess, S., Kruger, C., Stelter, F., et al. (1995). Soluble lipopolysaccharide receptor (CD14) is released via two different mechanisms from human monocytes and CD14 transfectants. European Journal of Immunology, 25, 604-610.
17. Burgmann, H., Winkler, S., Locker, G. J., Presterl, E., Laczika, K., Staudinger, T., et al. (1996). Increased serum concentration of soluble CD14 is a prognostic marker in Grampositive sepsis. Clinical Immunology and Immunopathology, 80, 307-310.
18. Caplan, M. S., & MacKendrick, W. (1993). Necrotizing enterocolitis: A review of pathogenetic mechanisms and implications for prevention. Pediatric Pathology, 13, 357-369.
19. Cauwels, A., Frei, K., Sansano, S., Fearns, C., Ulevitch, R., Zimmerli, W., et al. (1999). The origin and function of soluble CD14 in experimental bacterial meningitis. Journal of Immunology, 162, 4762-4772.
20. Cebra, J. J. (1999). Influences of microbiota on intestinal immune system development. American Journal of Clinical Nutrition, 69, 1046S-1051S.
21. Chow, J. C., Young, D. W., Golenbock, D. T., Christ, W. J., & Gusovsky, F. (1999). Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. Journal of Biological Chemistry, 274, 10689-10692.
22. Claud, E. C., Lu, L., Anton, P. M., Savidge, T., Walker, W. A., & Cherayil, B. J. (2004). Developmentally regulated IκB expression in intestinal epithelium and susceptibility to flagellin-induced inflammation. Proceedings of the National Academy of Sciences USA, 101, 7404-7408.
23. Cleveland, M. G., Gorham, J. D., Murphy, T. L., Tuomanen, E., & Murphy, K. M. (1996). Lipoteichoic acid preparations of Gram-positive bacteria induce interleukin-12 through a CD14-dependent pathway. Infectious Immunology, 64, 1906-1912.
24. da Silva, C. J., Soldau, K., Christen, U., Tobias, P. S., & Ulevitch, R. J. (2001). Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex. Transfer from CD14 to TLR4 and MD-2. Journal of Biological Chemistry, 276, 21129-21135.
25. Dentener, M. A., Bazil, V., Von Asmuth, E. J., Ceska, M., & Buurman, W. A. (1993). Involvement of CD14 in lipopolysaccharide-induced tumor necrosis factor-α, IL-6 and IL-8 release by human monocytes and alveolar macrophages. Journal of Immunology, 150, 2885-2891.
26. Diamond, G., Russell, J. P., & Bevins, C. L. (1996). Inducible expression of an antibiotic peptide gene in lipopolysaccharide-challenged tracheal epithelial cells. Proceedings of the National Academy of Sciences USA, 93, 5156-5160.
27. Dunstan, J. A., Roper, J., Mitoulas, L., Hartmann, P. E., Simmer, K.,&Prescott, S. L. (2004). The effect of supplementation with fish oil during pregnancy on breast milk immunoglobulin A, soluble CD14, cytokine levels and fatty acid composition. Clinical and Experimental Allergy, 34, 1237-1242.
28. Durieux, J. J., Vita, N., Popescu, O., Guette, F., Calzada-Wack, J., Munker, R., et al. (1994). The two soluble forms of the lipopolysaccharide receptor, CD14: Characterization and release by normal human monocytes. European Journal of Immunology, 24, 2006-2012.
29. Dziarski, R., Tapping, R. I., & Tobias, P. S. (1998). Binding of bacterial peptidoglycan to CD14. Journal of Biological Chemistry, 273, 8680-8690.
30. Edwards, C. A., & Parrett, A. M. (2002). Intestinal flora during the first months of life: New perspectives. British Journal of Nutrition, 88(Suppl 1), S11-S18.
31. Egerer, K., Feist, E., Rohr, U., Pruss, A., Burmester, G. R., & Dorner, T. (2000). Increased serum soluble CD14, ICAM-1 and E-selectin correlate with disease activity and prognosis in systemic lupus erythematosus. Lupus, 9, 614-621.
32. Elass, E., Masson, M., Mazurier, J., & Legrand, D. (2002). Lactoferrin inhibits the lipopolysaccharide- induced expression and proteoglycan-binding ability of interleukin-8 in human endothelial cells. Infectious Immunology, 70, 1860-1866.
33. Endo, S., Inada, K., Kasai, T., Takakuwa, T., Nakae, H., Kikuchi, M., et al. (1994). Soluble CD14 (sCD14) levels in patients with multiple organ failure (MOF). Research Communications in Chemical Pathology and Pharmocology, 84, 17-25.
34. Espevik, T., Otterlei, M., Skjak-Braek, G., Ryan, L., Wright, S. D., & Sundan, A. (1993). The involvement of CD14 in stimulation of cytokine production by uronic acid polymers. European Journal of Immunology, 23, 255-261.
35. Espinoza, J., Chaiworapongsa, T., Romero, R., Gomez, R., Kim, J. C., Yoshimatsu, J., et al. (2002). Evidence of participation of soluble CD14 in the host response to microbial invasion of the amniotic cavity and intra-amniotic inflammation in term and preterm gestations. Journal of Maternal and Fetal Neonatal Medicine, 12, 304-312.
36. Falk, P. G., Hooper, L. V., Midtvedt, T.,&Gordon, J. I. (1998). Creating and maintaining the gastrointestinal ecosystem: What we know and need to know from gnotobiology. Microbiology and .Molecular Biology Reviews, 62, 1157-1170.
37. Fernandez-Real, J. M., Broch, M., Richart, C., Vendrell, J., Lopez-Bermejo, A., & Ricart, W. (2003). CD14 monocyte receptor, involved in the inflammatory cascade, and insulin sensitivity. Journal of Clinical Endocrinology and Metabolism, 88, 1780-1784.
38. Ferrero, E., & Goyert, S. M. (1988). Nucleotide sequence of the gene encoding the monocyte differentiation antigen, CD14. Nucleic Acids Research, 16, 4173.
39. Ferrero, E., Hsieh, C. L., Francke, U., & Goyert, S. M. (1990). CD14 is a member of the family of leucine-rich proteins and is encoded by a gene syntenic with multiple receptor genes. Journal of Immunology, 145, 331-336.
40. Filipp, D., Alizadeh-Khiavi, K., Richardson, C., Palma, A., Paredes, N., Takeuchi, O., et al. (2001). Soluble CD14 enriched in colostrum and milk induces B cell growth and differentiation. Proceedings of the National Academy of Sciences USA, 98, 603-608.
41. Frey, E. A., Miller, D. S., Jahr, T. G., Sundan, A., Bazil, V., Espevik, T., et al. (1992). Soluble CD14 participates in the response of cells to lipopolysaccharide. Journal of Experimental Medicine, 176, 1665-1671.
42. Funda, D. P., Tuckova, L., Farre, M. A., Iwase, T., Moro, I., & Tlaskalova-Hogenova, H. (2001). CD14 is expressed and released as soluble CD14 by human intestinal epithelial cells in vitro: Lipopolysaccharide activation of epithelial cells revisited. Infectious Immunology, 69, 3772-3781.
43. Fusunyan, R. D., Nanthakumar, N. N., Baldeon, M. E., & Walker, W. A. (2001). Evidence for an innate immune response in the immature human intestine: Toll-like receptors on fetal enterocytes. Pediatric Research, 49, 589-593.
44. Gallay, P., Jongeneel, C. V., Barras, C., Burnier, M., Baumgartner, J. D., Glauser, M. P., et al. (1993). Short time exposure to lipopolysaccharide is sufficient to activate human monocytes. Journal of Immunology, 150, 5086-5093.
45. Gardella, C., Hitti, J., Martin, T. R., Ruzinski, J. T., & Eschenbach, D. (2001). Amniotic fluid lipopolysaccharide-binding protein and soluble CD14 as mediators of the inflammatory response in preterm labor. American Journal of Obstetrics and Gynecology, 184, 1241-1248.
46. Gegner, J. A., Ulevitch, R. J., & Tobias, P. S. (1995). Lipopolysaccharide (LPS) signal transduction and clearance. Dual roles for LPS binding protein and membrane CD14. Journal of Biological Chemistry, 270, 5320-5325.
47. Goldblum, S. E., Brann, T. W., Ding, X., Pugin, J., & Tobias, P. S. (1994). Lipopolysaccharide (LPS)-binding protein and soluble CD14 function as accessory molecules for LPSinduced changes in endothelial barrier function, in vitro. Journal of Clinical Investigations, 93, 692-702.
48. Goyert, S. M., & Ferrero, E. (1987). Biochemical analysis of myeloid antigens and cDNA expression of gp 55 (CD14). In A. McMichael (Ed.), Leucocyte Typing III (pp. 613-619). Oxford: Oxford University Press.
49. Goyert, S. M., Ferrero, E., Rettig, W. J., Yenamandra, A. K., Obata, F., & Le Beau, M. M. (1988). The CD14 monocyte differentiation antigen maps to a region encoding growth factors and receptors. Science, 239, 497-500.
50. Grunwald, U., Kruger, C., Westermann, J., Lukowsky, A., Ehlers, M., & Schutt, C. (1992). An enzyme-linked immunosorbent assay for the quantification of solubilized CD14 in biological fluids. Journal of .Immunology Methods, 155, 225-232.
51. Grunwald, U., Kruger, C., & Schutt, C. (1993). Endotoxin-neutralizing capacity of soluble CD14 is a highly conserved specific function. Circulatory Shock, 39, 220-225.
52. Grunwald, U., Fan, X., Jack, R. S., Workalemahu, G., Kallies, A., Stelter, F., et al. (1996). Monocytes can phagocytose Gram-negative bacteria by a CD14-dependent mechanism. Journal of Immunology, 157, 4119-4125.
53. Guerra, S., Carla, L., I, LeVan, T. D., Wright, A. L., Martinez, F. D., & Halonen, M. (2004a). The differential effect of genetic variation on soluble CD14 levels in human plasma and milk. American Journal of Reproductive Immunology, 52, 204-211.
54. Guerra, S., Lohman, I. C., Halonen, M., Martinez, F. D., & Wright, A. L. (2004b). Reduced interferon gamma production and soluble CD14 levels in early life predict recurrent wheezing by 1 year of age. American Journal of Respiration and Critical Care Medicine, 169, 70-76.
55. Gupta, D., Kirkland, T. N., Viriyakosol, S., & Dziarski, R. (1996). CD14 is a cell-activating receptor for bacterial peptidoglycan. Journal of Biological Chemistry, 271, 23310-23316.
56. Hailman, E., Lichenstein, H. S., Wurfel, M. M., Miller, D. S., Johnson, D. A., Kelley, M., et al. (1994). Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14. Journal of Experimental Medicine, 179, 269-277.
57. Haller, D., Bode, C., Hammes, W. P., Pfeifer, A. M., Schiffrin, E. J., & Blum, S. (2000). Non-pathogenic bacteria elicit a differential cytokine response by intestinal epithelial cell/ leucocyte co-cultures. Gut, 47, 79-87.
58. Harris, C. L., Vigar, M. A., Rey Nores, J. E., Horejsi, V., Labeta, M. O., & Morgan, B. P. (2001). The lipopolysaccharide co-receptor CD14 is present and functional in seminal plasma and expressed on spermatozoa. Immunology, 104, 317-323.
59. Hattor, Y., Kasai, K., Akimoto, K.,&Thiemermann, C. (1997). Induction ofNOsynthesis by lipoteichoic acid from Staphylococcus aureus in J774 macrophages: Involvement of a CD14-dependent pathway. Biochemistry and Biophysics Research Community, 233, 375-379.
60. Haversen, L., Ohlsson, B. G., Hahn-Zoric, M., Hanson, L. A., & Mattsby-Baltzer, I. (2002). Lactoferrin down-regulates the LPS-induced cytokine production in monocytic cells via NF-κB. Cell Immunology, 220, 83-95.
61. Haziot, A., Chen, S., Ferrero, E., Low, M. G., Silber, R., & Goyert, S. M. (1988). The monocyte differentiation antigen, CD14, is anchored to the cell membrane by a phosphatidylinositol linkage. Journal of Immunology, 141, 547-552.
62. Haziot, A., Rong, G. W., Silver, J., & Goyert, S. M. (1993a). Recombinant soluble CD14 mediates the activation of endothelial cells by lipopolysaccharide. Journal of Immunology, 151, 1500-1507.
63. Haziot, A., Tsuberi, B. Z., & Goyert, S. M. (1993b). Neutrophil CD14: Biochemical properties and role in the secretion of tumor necrosis factor-alpha in response to lipopolysaccharide. Journal of Immunology, 150, 5556-5565.
64. Haziot, A., Rong, G. W., Bazil, V., Silver, J., & Goyert, S. M. (1994). Recombinant soluble CD14 inhibits LPS-induced tumor necrosis factor-alpha production by cells in whole blood. Journal of Immunology, 152, 5868-5876.
65. Haziot, A., Rong, G. W., Lin, X. Y., Silver, J., & Goyert, S. M. (1995). Recombinant soluble CD14 prevents mortality in mice treated with endotoxin (lipopolysaccharide). Journal of Immunology, 154, 6529-6532.
66. Heumann, D., Glauser, M. P., & Calandra, T. (1998). Molecular basis of host-pathogen interaction in septic shock. Current Opinions in Microbiology, 1, 49-55.
67. Hollak, C. E., Evers, L., Aerts, J. M., & van Oers, M. H. (1997). Elevated levels of M-CSF, sCD14 and IL8 in type 1 Gaucher disease. Blood Cells Molecular Disease, 23, 201-212.
68. Horneff, G., Sack, U., Kalden, J. R., Emmrich, F., & Burmester, G. R. (1993). Reduction of monocyte-macrophage activation markers upon anti-CD4 treatment. Decreased levels of IL-1, IL-6, neopterin and soluble CD14 in patients with rheumatoid arthritis. Clinical Experiments in Immunology, 91, 207-213.
69. Hoy, C., Millar, M. R., MacKay, P., Godwin, P. G., Langdale, V., & Levene, M. I. (1990). Quantitative changes in faecal microflora preceding necrotising enterocolitis in premature neonates. Archives of Disease in Childhood, 65, 1057-1059.
70. Humphries, J. D., & Humphries, M. J. (2007). CD14 is a ligand for the integrin α4β1. FEBS Letters, 581, 757-763.
71. Ikeda, A., Takata, M., Taniguchi, T., & Sekikawa, K. (1997). Molecular cloning of bovine CD14 gene. Journal of Veterinary Medicine and Science, 59, 715-719.
72. Ismail, A. S., & Hooper, L. V. (2005). Epithelial cells and their neighbors. IV. Bacterial contributions to intestinal epithelial barrier integrity. American Journal of Physiology: Gastrointestinal and Liver Physiology, 289, G779-G784.
73. Jack, R. S., Grunwald, U., Stelter, F., Workalemahu, G., & Schutt, C. (1995). Both membrane- bound and soluble forms of CD14 bind to Gram-negative bacteria. European Journal of Immunology, 25, 1436-1441.
74. Jack, R. S., Fan, X., Bernheiden, M., Rune, G., Ehlers, M., Weber, A., et al. (1997). Lipopolysaccharide-binding protein is required to combat a murine Gram-negative bacterial infection. Nature, 389, 742-745.
75. Jackson, K. M., & Nazar, A. M. (2006). Breastfeeding, the immune response, and long-term health. Journal of American Osteopath Association, 106, 203-207.
76. Jacque, B., Stephan, K., Smirnova, I., Kim, B., Gilling, D., & Poltorak, A. (2006). Mice expressing high levels of soluble CD14 retain LPS in the circulation and are resistant to LPS-induced lethality. European Journal of Immunology, 36, 3007-3016.
77. Jilling, T., Simon, D., Lu, J., Meng, F. J., Li, D., Schy, R., et al. (2006). The roles of bacteria and TLR4 in rat and murine models of necrotizing enterocolitis. Journal of Immunology, 177, 3273-3282.
78. Jones, C. A., Holloway, J. A., Popplewell, E. J., Diaper, N. D., Holloway, J. W., Vance, G. H., et al. (2002). Reduced soluble CD14 levels in amniotic fluid and breast milk are associated with the subsequent development of atopy, eczema, or both. Journal of Allergy and Clinical Immunology, 109, 858-866.
79. Kaisho, T., & Akira, S. (2006). Toll-like receptor function and signaling. Journal of Allergy and Clinical Immunology, 117, 979-987.
80. Kirjavainen, P. V., Arvola, T., Salminen, S. J., & Isolauri, E. (2002). Aberrant composition of gut microbiota of allergic infants: A target of bifidobacterial therapy at weaning? Gut, 51, 51-55.
81. Kirkland, T. N., Finley, F., Leturcq, D., Moriarty, A., Lee, J. D., Ulevitch, R. J., et al. (1993). Analysis of lipopolysaccharide binding by CD14. Journal of Biological Chemistry, 268, 24818-24823.
82. Kitchens, R. L.,&Munford, R. S. (1995). Enzymatically deacylated lipopolysaccharide (LPS) can antagonize LPS at multiple sites in the LPS recognition pathway. Journal of Biological Chemistry, 270, 9904-9910.
83. Kitchens, R. L., & Thompson, P. A. (2005). Modulatory effects of sCD14 and LBP on LPShost cell interactions. Journal of Endotoxin Research, 11, 225-229.
84. Kitchens, R. L., Wolfbauer, G., Albers, J. J., & Munford, R. S. (1999). Plasma lipoproteins promote the release of bacterial lipopolysaccharide from the monocyte cell surface. Journal of Biological Chemistry, 274, 34116-34122.
85. Kitchens, R. L., Thompson, P. A., Viriyakosol, S., O'Keefe, G. E., & Munford, R. S. (2001). Plasma CD14 decreases monocyte responses to LPS by transferring cell-bound LPS to plasma lipoproteins. Journal of Clinical Investigations, 108, 485-493.
86. Kol, A., Lichtman, A. H., Finberg, R. W., Libby, P.,&Kurt-Jones, E. A. (2000). Cutting edge: Heat shock protein (HSP) 60 activates the innate immune response: CD14 is an essential receptor for HSP60 activation of mononuclear cells. Journal of Immunology, 164, 13-17.
87. Kruger, C., Schutt, C., Obertacke, U., Joka, T., Muller, F. E., Knoller, J., et al. (1991). Serum CD14 levels in polytraumatized and severely burned patients. Clinical Experiments in Immunology, 85, 297-301.
88. Kull, I., Almqvist, C., Lilja, G., Pershagen, G., & Wickman, M. (2004). Breast-feeding reduces the risk of asthma during the first 4 years of life. Journal of Allergy and Clinical Immunology, 114, 755-760.
89. Kusunoki, T., & Wright, S. D. (1996). Chemical characteristics of Staphylococcus aureus molecules that have CD14-dependent cell-stimulating activity. Journal of Immunology, 157, 5112-5117.
90. Kusunoki, T., Hailman, E., Juan, T. S., Lichenstein, H. S., & Wright, S. D. (1995). Molecules from Staphylococcus aureus that bind CD14 and stimulate innate immune responses. Journal of Experimental Medicine, 182, 1673-1682.
91. Labeta, M. O., Durieux, J. J., Fernandez, N., Herrmann, R., & Ferrara, P. (1993). Release from a human monocyte-like cell line of two different soluble forms of the lipopolysaccharide receptor, CD14. European Journal of Immunology, 23, 2144-2151.
92. Labeta, M. O., Vidal, K., Nores, J. E., Arias, M., Vita, N., Morgan, B. P., et al. (2000). Innate recognition of bacteria in human milk is mediated by a milk-derived highly expressed pattern recognition receptor, soluble CD14. Journal of Experimental Medicine, 191, 1807-1812.
93. Laitinen, K., Hoppu, U., Hamalainen, M., Linderborg, K., Moilanen, E., & Isolauri, E. (2006). Breast milk fatty acids may link innate and adaptive immune regulation: Analysis of soluble CD14, prostaglandin E2, and fatty acids. Pediatric Research, 59, 723-727.
94. Landmann, R., Fisscher, A. E., & Obrecht, J. P. (1992). Interferon-and interleukin-4 downregulate soluble CD14 release in human monocytes and macrophages. Journal of Leukocyte Biology, 52, 323-330.
95. Landmann, R., Zimmerli, W., Sansano, S., Link, S., Hahn, A., Glauser, M. P., et al. (1995). Increased circulating soluble CD14 is associated with high mortality in Gram-negative septic shock. Journal of Infectious Diseases, 171, 639-644.
96. Landmann, R., Reber, A. M., Sansano, S., & Zimmerli, W. (1996). Function of soluble CD14 in serum from patients with septic shock. Journal of Infectious Disease, 173, 661-668.
97. Lauener, R. P., Birchler, T., Adamski, J., Braun-Fahrlander, C., Bufe, A., Herz, U., et al. (2002). Expression of CD14 and Toll-like receptor 2 in farmers' and non-farmers' children. Lancet, 360, 465-466.
98. Lawrence, R. M. (2005). Host-resistance factors and immunologic significance of human milk. In R. A. Lawrence & R. M. Lawrence (Eds.), Breastfeeding. A Guide for the Medical Profession (pp. 171-214). Philadelphia: Elsevier Mosby.
99. Lebouder, E., Rey-Nores, J. E., Raby, A. C., Affolter, M., Vidal, K., Thornton, C. A., et al. (2006). Modulation of neonatal microbial recognition: TLR-mediated innate immune responses are specifically and differentially modulated by human milk. Journal of Immunology, 176, 3742-3752.
100. Lee, J. W., Paape, M. J., Elsasser, T. H., & Zhao, X. (2003a). Elevated milk soluble CD14 in bovine mammary glands challenged with Escherichia coli lipopolysaccharide. Journal of Dairy Science, 86, 2382-2389.
101. Lee, J. W., Paape, M. J., Elsasser, T. H., & Zhao, X. (2003b). Recombinant soluble CD14 reduces severity of intramammary infection by Escherichia coli. Infectious Immunology, 71, 4034-4039.
102. Lee, J. W., Paape, M. J., & Zhao, X. (2003c). Recombinant bovine soluble CD14 reduces severity of experimental Escherichia coli mastitis in mice. Veterinary Research, 34, 307-316.
103. LeVan, T. D., Guerra, S., Klimecki, W., Vasquez, M. M., Lohman, I. C., Martinez, F. D., et al. (2006). The impact of CD14 polymorphisms on the development of soluble CD14 levels during infancy. Genes and Immunology, 7, 77-80.
104. Liu, S., Khemlani, L. S., Shapiro, R. A., Johnson, M. L., Liu, K., Geller, D. A., et al. (1998). Expression of CD14 by hepatocytes: Upregulation by cytokines during endotoxemia. Infectious Immunology, 66, 5089-5098.
105. Lonnerdal, B. (2003). Nutritional and physiologic significance of human milk proteins. American Journal of Clinical Nutrition, 77, 1537S-1543S.
106. Loppnow, H., Stelter, F., Schonbeck, U., Schluter, C., Ernst, M., Schutt, C., et al. (1995). Endotoxin activates human vascular smooth muscle cells despite lack of expression of CD14 mRNA or endogenous membrane CD14. Infectious Immunology, 63, 1020-1026.
107. Lotz, M., Gutle, D., Walther, S., Menard, S., Bogdan, C., & Hornef, M. W. (2006). Postnatal acquisition of endotoxin tolerance in intestinal epithelial cells. Journal of Experimental Medicine, 203, 973-984.
108. Lutterotti, A., Kuenz, B., Gredler, V., Khalil, M., Ehling, R., Gneiss, C., et al. (2006). Increased serum levels of soluble CD14 indicate stable multiple sclerosis. Journal of Neuroimmunology, 181, 145-149.
109. Macpherson, A. J., & Harris, N. L. (2004). Interactions between commensal intestinal bacteria and the immune system. Nature Reviews Immunology, 4, 478-485.
110. Maliszewski, C. R., Ball, E. D., Graziano, R. F., & Fanger, M. W. (1985). Isolation and characterization of My23, a myeloid cell-derived antigen reactive with the monoclonal antibody AML-2-23. Journal of Immunology, 135, 1929-1936.
111. Martin, T. R., Mathison, J. C., Tobias, P. S., Leturcq, D. J., Moriarty, A. M., Maunder, R. J., et al. (1992). Lipopolysaccharide binding protein enhances the responsiveness of alveolar macrophages to bacterial lipopolysaccharide. Implications for cytokine production in normal and injured lungs. Journal of Clinical Investigations, 90, 2209-2219.
112. Mathison, J. C., Tobias, P. S., Wolfson, E., & Ulevitch, R. J. (1992). Plasma lipopolysaccharide (LPS)-binding protein.Akey component in macrophage recognition of Gram-negative LPS. Journal of Immunology, 149, 200-206.
113. Matsuura, K., Ishida, T., Setoguchi, M., Higuchi, Y., Akizuki, S., & Yamamoto, S. (1994). Upregulation of mouse CD14 expression in Kupffer cells by lipopolysaccharide. Journal of Experimental Medicine, 179, 1671-1676.
114. Matzinger, P. (2002). The danger model: A renewed sense of self. Science, 296, 301-305.
115. Nasu, N., Yoshida, S., Akizuki, S., Higuchi, Y., Setoguchi, M., & Yamamoto, S. (1991). Molecular and physiological properties of murine CD14. International Immunology, 3, 205-213.
116. Nemchinov, L. G., Paape, M. J., Sohn, E. J., Bannerman, D. D., Zarlenga, D. S., & Hammond, R. W. (2006). Bovine CD14 receptor produced in plants reduces severity of intramammary bacterial infection. FASEB Journal, 20, 1345-1351.
117. Newman, S. L., Chaturvedi, S., & Klein, B. S. (1995). The WI-1 antigen of Blastomyces dermatitidis yeasts mediates binding to human macrophage CD11b/CD18 (CR3) and CD14. Journal of Immunology, 154, 753-761.
118. Nockher, W. A., Wigand, R., Schoeppe, W., & Scherberich, J. E. (1994). Elevated levels of soluble CD14 in serum of patients with systemic lupus erythematosus. Clinical Experiments in Immunology, 96, 15-19.
119. O'Neill, L. A. (2002). Signal transduction pathways activated by the IL-1 receptor/Tolllike receptor superfamily. Current Topics in Microbiology and Immunology, 270, 47-61.
120. O'Neill, L. A., Dunne, A., Edjeback, M., Gray, P., Jefferies, C., & Wietek, C. (2003). Mal and MyD88: Adapter proteins involved in signal transduction by Toll-like receptors. Journal of Endotoxin Research, 9, 55-59.
121. Otte, J. M., Cario, E., & Podolsky, D. K. (2004). Mechanisms of cross hyporesponsiveness to Toll-like receptor bacterial ligands in intestinal epithelial cells. Gastroenterology, 126, 1054-1070.
122. Pugin, J., Schurer-Maly, C. C., Leturcq, D., Moriarty, A., Ulevitch, R. J., & Tobias, P. S. (1993). Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proceedings of the National Academy of Sciences USA, 90, 2744-2748.
123. Pugin, J., Heumann, I. D., Tomasz, A., Kravchenko, V. V., Akamatsu, Y., Nishijima, M., et al. (1994). CD14 is a pattern recognition receptor. Immunity, 1, 509-516.
124. Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., & Medzhitov, R. (2004). Recognition of commensal microflora by Toll-like receptors is required for intestinal homeostasis. Cell, 118, 229-241.
125. Re, F., & Strominger, J. L. (2001). Toll-like receptor 2 (TLR2) and TLR4 differentially activate human dendritic cells. Journal of Biological Chemistry, 276, 37692-37699.
126. Read, M. A., Cordle, S. R., Veach, R. A., Carlisle, C. D., & Hawiger, J. (1993). Cell-free pool of CD14 mediates activation of transcription factor NF-kB by lipopolysaccharide in human endothelial cells. Proceedings of the National Academy of Sciences USA, 90, 9887-9891.
127. Rey Nores, J. E., Bensussan, A., Vita, N., Stelter, F., Arias, M. A., Jones, M., et al. (1999). Soluble CD14 acts as a negative regulator of human T cell activation and function. European Journal of Immunology, 29, 265-276.
128. Rinne, M., Kalliomaki, M., Arvilommi, H., Salminen, S., & Isolauri, E. (2005). Effect of probiotics and breastfeeding on the bifidobacterium and lactobacillus/enterococcus microbiota and humoral immune responses. Journal of Pediatrics, 147, 186-191.
129. Ronnestad, A., Abrahamsen, T. G., Medbo, S., Reigstad, H., Lossius, K., Kaaresen, P. I., et al. (2005). Septicemia in the first week of life in a Norwegian national cohort of extremely premature infants. Pediatrics, 115, e262-e268.
130. Rothenbacher, D., Weyermann, M., Beermann, C., & Brenner, H. (2005). Breastfeeding, soluble CD14 concentration in breast milk and risk of atopic dermatitis and asthma in early childhood: Birth cohort study. Clinical and Experimental Allergy, 35, 1014-1021.
131. Sano, H., Chiba, H., Iwaki, D., Sohma, H., Voelker, D. R., & Kuroki, Y. (2000). Surfactant proteins A and D bind CD14 by different mechanisms. Journal of Biological Chemistry, 275, 22442-22451.
132. Savedra, R., Jr., Delude, R. L., Ingalls, R. R., Fenton, M. J., & Golenbock, D. T. (1996). Mycobacterial lipoarabinomannan recognition requires a receptor that shares components of the endotoxin signaling system. Journal of Immunology, 157, 2549-2554.
133. Schmitz, G., & Orso, E. (2002). CD14 signalling in lipid rafts: New ligands and co-receptors. Current Opinions in Lipidology, 13, 513-521.
134. Schroder, N. W., Morath, S., Alexander, C., Hamann, L., Hartung, T., Zahringer, U., et al. (2003). Lipoteichoic acid (LTA) of Streptococcus pneumoniae and Staphylococcus aureus activates immune cells via Toll-like receptor (TLR)-2, lipopolysaccharide-binding protein (LBP), and CD14, whereas TLR-4 and MD-2 are not involved. Journal of Biological Chemistry, 278, 15587-15594.
135. Schumann, R. R., Leong, S. R., Flaggs, G. W., Gray, P. W., Wright, S. D., Mathison, J. C., et al. (1990). Structure and function of lipopolysaccharide binding protein. Science, 249, 1429-1431.
136. Schumann, R. R., Rietschel, E. T., & Loppnow, H. (1994). The role of CD14 and lipopolysaccharide- binding protein (LBP) in the activation of different cell types by endotoxin. Medical Microbiology and Immunology (Berlin), 183, 279-297.
137. Schutt, C., Schilling, T., Grunwald, U., Schonfeld, W., & Kruger, C. (1992). Endotoxinneutralizing capacity of soluble CD14. Research in Immunology, 143, 71-78.
138. Schwandner, R., Dziarski, R., Wesche, H., Rothe, M., & Kirschning, C. J. (1999). Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by Toll-like receptor 2. Journal of Biological Chemistry, 274, 17406-17409.
139. Scott, P., Ma, H., Viriyakosol, S., Terkeltaub, R., & Liu-Bryan, R. (2006). Engagement of CD14 mediates the inflammatory potential of monosodium urate crystals. Journal of Immunology, 177, 6370-6378.
140. Sellati, T. J., Bouis, D. A., Kitchens, R. L., Darveau, R. P., Pugin, J., Ulevitch, R. J., et al. (1998). Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides activate monocytic cells via a CD14-dependent pathway distinct from that used by lipopolysaccharide. Journal of Immunology, 160, 5455-5464.
141. Setoguchi, M., Nasu, N., Yoshida, S., Higuchi, Y., Akizuki, S., & Yamamoto, S. (1989). Mouse and human CD14 (myeloid cell-specific leucine-rich glycoprotein) primary structure deduced from cDNA clones. Biochimica et Biophysica Acta, 1008, 213-222.
142. Simmons, D. L., Tan, S., Tenen, D. G., Nicholson-Weller, A., & Seed, B. (1989). Monocyte antigen CD14 is a phospholipid anchored membrane protein. Blood, 73, 284-289.
143. Soell, M., Lett, E., Holveck, F., Scholler, M., Wachsmann, D., & Klein, J. P. (1995). Activation of human monocytes by streptococcal rhamnose glucose polymers is mediated by CD14 antigen, and mannan binding protein inhibits TNF-α release. Journal of Immunology, 154, 851-860.
144. Sohn, E. J., Paape, M. J., Bannerman, D. D., Connor, E. E., Fetterer, R. H., & Peters, R. R. (2007). Shedding of sCD14 by bovine neutrophils following activation with bacterial lipopolysaccharide results in down-regulation of IL-8. Veterinary Research, 38, 95-108.
145. Song, P. I., Park, Y. M., Abraham, T., Harten, B., Zivony, A., Neparidze, N., et al. (2002). Human keratinocytes express functional CD14 and Toll-like receptor 4. Journal of Investigations in Dermatology, 119, 424-432.
146. Steinwender, G., Schimpl, G., Sixl, B., Kerbler, S., Ratschek, M., Kilzer, S., et al. (1996). Effect of early nutritional deprivation and diet on translocation of bacteria from the gastrointestinal tract in the newborn rat. Pediatric Research, 39, 415-420.
147. Stelter, F., Pfister, M., Bernheiden, M., Jack, R. S., Bufler, P., Engelmann, H., et al. (1996). The myeloid differentiation antigen CD14 is N- and O-glycosylated. Contribution of N-linked glycosylation to different soluble CD14 isoforms. European Journal of Biochemistry, 236, 457-464.
148. Stelter, F., Witt, S., Furll, B., Jack, R. S., Hartung, T., & Schutt, C. (1998). Different efficacy of soluble CD14 treatment in high- and low-dose LPS models. European Journal of Clinical Investigations, 28, 205-213.
149. Stoiser, B., Knapp, S., Thalhammer, F., Locker, G. J., Kofler, J., Hollenstein, U., et al. (1998). Time course of immunological markers in patients with the systemic inflammatory response syndrome: Evaluation of sCD14, sVCAM-1, sELAM-1, MIP-1a and TGF-b2. European Journal of Clinical Investigations, 28, 672-678.
150. Strachan, D. P. (1989). Hay fever, hygiene, and household size. British Medical Journal, 299, 1259-1260.
151. Sugawara, S., Sugiyama, A., Nemoto, E., Rikiishi, H., & Takada, H. (1998). Heterogeneous expression and release of CD14 by human gingival fibroblasts: Characterization and CD14-mediated interleukin-8 secretion in response to lipopolysaccharide. Infectious Immunology, 66, 3043-3049.
152. Sugiyama, T., & Wright, S. D. (2001). Soluble CD14 mediates efflux of phospholipids from cells. Journal of Immunology, 166, 826-831.
153. Takai, N., Kataoka, M., Higuchi, Y., Matsuura, K., & Yamamoto, S. (1997). Primary structure of rat CD14 and characteristics of rat CD14, cytokine, and NO synthase mRNA expression in mononuclear phagocyte system cells in response to LPS. Journal of Leukocyte Biology, 61, 736-744.
154. Takeshita, S., Nakatani, K., Tsujimoto, H., Kawamura, Y., Kawase, H., & Sekine, I. (2000). Increased levels of circulating soluble CD14 in Kawasaki disease. Clinical Experiments in Immunology, 119, 376-381.
155. Takeuchi, O., Hoshino, K., Kawai, T., Sanjo, H., Takada, H., Ogawa, T., et al. (1999). Differential roles of TLR2 and TLR4 in recognition of Gram-negative and Gram-positive bacterial cell wall components. Immunity, 11, 443-451.
156. Thomas, C. J., Kapoor, M., Sharma, S., Bausinger, H., Zyilan, U., Lipsker, D., et al. (2002). Evidence of a trimolecular complex involving LPS, LPS binding protein and soluble CD14 as an effector of LPS response. FEBS Letters, 531, 184-188.
157. Tobias, P. S., & Ulevitch, R. J. (1993). Lipopolysaccharide binding protein and CD14 in LPS dependent macrophage activation. Immunobiology, 187, 227-232.
158. Tobias, P. S., Soldau, K., & Ulevitch, R. J. (1986). Isolation of a lipopolysaccharidebinding acute phase reactant from rabbit serum. Journal of Experimental Medicine, 164, 777-793.
159. Tobias, P. S., Mathison, J., Mintz, D., Lee, J. D., Kravchenko, V., Kato, K., et al. (1992). Participation of lipopolysaccharide-binding protein in lipopolysaccharide-dependent macrophage activation. American Journal of Respiratory Cell and Molecular Biology, 7, 239-245.
160. Uehara, A., Sugawara, S., Watanabe, K., Echigo, S., Sato, M., Yamaguchi, T., et al. (2003). Constitutive expression of a bacterial pattern recognition receptor, CD14, in human salivary glands and secretion as a soluble form in saliva. Clinical and Diagnostic Laboratory Immunology, 10, 286-292.
161. van Saene, H. K., Taylor, N., Donnell, S. C., Glynn, J., Magnall, V. L., Okada, Y., et al. (2003). Gut overgrowth with abnormal flora: The missing link in parenteral nutritionrelated sepsis in surgical neonates. European Journal of Clinical Nutrition, 57, 548-553.
162. Vangroenweghe, F., Rainard, P., Paape, M., Duchateau, L., & Burvenich, C. (2004). Increase of Escherichia coli inoculum doses induces faster innate immune response in primiparous cows. Journal of Dairy Science, 87, 4132-4144.
163. Verhasselt, V., Buelens, C., Willems, F., De Groote, D., Haeffner-Cavaillon, N., & Goldman, M. (1997). Bacterial lipopolysaccharide stimulates the production of cytokines and the expression of costimulatory molecules by human peripheral blood dendritic cells: Evidence for a soluble CD14-dependent pathway. Journal of Immunology, 158, 2919-2925.
164. Vidal, K., Labeta, M. O., Schiffrin, E. J., & Donnet-Hughes, A. (2001). Soluble CD14 in human breast milk and its role in innate immune responses. Acta Odontologica Scandinavica, 59, 330-334.
165. Vidal, K., Donnet-Hughes, A., & Granato, D. (2002). Lipoteichoic acids from Lactobacillus johnsonii strain La1 and Lactobacillus acidophilus strain La10 antagonize the responsiveness of human intestinal epithelial HT29 cells to lipopolysaccharide and Gram-negative bacteria. Infectious Immunology, 70, 2057-2064.
166. Vita, N., Lefort, S., Sozzani, P., Reeb, R., Richards, S., Borysiewicz, L. K., et al. (1997). Detection and biochemical characteristics of the receptor for complexes of soluble CD14 and bacterial lipopolysaccharide. Journal of Immunology, 158, 3457-3462.
167. Watanabe, A., Takeshita, A., Kitano, S., & Hanazawa, S. (1996). CD14-mediated signal pathway of Porphyromonas gingivalis lipopolysaccharide in human gingival fibroblasts. Infectious Immunology, 64, 4488-4494.
168. Weidemann, B., Brade, H., Rietschel, E. T., Dziarski, R., Bazil, V., Kusumoto, S., et al. (1994). Soluble peptidoglycan-induced monokine production can be blocked by anti-CD14 monoclonal antibodies and by lipid A partial structures. Infectious Immunology, 62, 4709-4715.
169. Weidemann, B., Schletter, J., Dziarski, R., Kusumoto, S., Stelter, F., Rietschel, E. T., et al. (1997). Specific binding of soluble peptidoglycan and muramyldipeptide to CD14 on human monocytes. Infectious Immunology, 65, 858-864.
170. Wooten, R. M., Morrison, T. B., Weis, J. H., Wright, S. D., Thieringer, R., & Weis, J. J. (1998). The role of CD14 in signaling mediated by outer membrane lipoproteins of Borrelia burgdorferi. Journal of Immunology, 160, 5485-5492.
171. Wright, S. D., Ramos, R. A., Tobias, P. S., Ulevitch, R. J., & Mathison, J. C. (1990). CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science, 249, 1431-1433.
172. Wuthrich, B., Kagi, M. K.,& Joller-Jemelka, H. (1992). Soluble CD14 but not interleukin-6 is a new marker for clinical activity in atopic dermatitis. Archives in Dermatology Research, 284, 339-342.
173. Yaegashi, Y., Shirakawa, K., Sato, N., Suzuki, Y., Kojika, M., Imai, S., et al. (2005). Evaluation of a newly identified soluble CD14 subtype as a marker for sepsis. Journal of Infectious Chemotherapy, 11, 234-238.
174. Yu, B., Hailman, E., & Wright, S. D. (1997). Lipopolysaccharide binding protein and soluble CD14 catalyze exchange of phospholipids. Journal of Clinical Investigations, 99, 315-324.
175. Yu, S., Nakashima, N., Xu, B. H., Matsuda, T., Izumihara, A., Sunahara, N., et al. (1998). Pathological significance of elevated soluble CD14 production in rheumatoid arthritis: In the presence of soluble CD14, lipopolysaccharides at low concentrations activate RA synovial fibroblasts. Rheumatology International, 17, 237-243.
176. Zalai, C. V., Kolodziejczyk, M. D., Pilarski, L., Christov, A., Nation, P. N., Lundstrom- Hobman, M., et al. (2001). Increased circulating monocyte activation in patients with unstable coronary syndromes. Journal of the American College of Cardiology, 38, 1340-1347.
177. Zdolsek, H. A., & Jenmalm, M. C. (2004). Reduced levels of soluble CD14 in atopic children. Clinical Experiments in Allergy, 34, 532-539.
178. Zhang, Y., Doerfler, M., Lee, T. C., Guillemin, B., & Rom, W. N. (1993). Mechanisms of stimulation of interleukin-1β and tumor necrosis factor-a by Mycobacterium tuberculosis components. Journal of Clinical Investigations, 91, 2076-2083.
179. Zoetendal, E. G., Akkermans, A. D., & De Vos, W. M. (1998). Temperature gradient gel electrophoresis analysis of 16S rRNA from human fecal samples reveals stable and hostspecific communities of active bacteria. Applied and Environmental Microbiology, 64, 3854-3859.